Current Approaches to COVID-19: Therapy and Prevention.
Coronavirus
Coronavirus disease-2019
Heparin
Hydroxychloroquine
Remdesvir
SARS-CoV-2
Tocilizumab
Journal
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine
ISSN: 0972-5229
Titre abrégé: Indian J Crit Care Med
Pays: India
ID NLM: 101208863
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
entrez:
2
11
2020
pubmed:
3
11
2020
medline:
3
11
2020
Statut:
ppublish
Résumé
The coronavirus disease-2019 (COVID-19) pandemic has affected millions of people worldwide. As our understanding of the disease is evolving, our approach to the patient management is also changing swiftly. Available new evidence is helping us take radical decisions in COVID-19 management. We searched for inclusion of the published literature on treatment of COVID-19 from around the globe. All relevant evidences available till the time of submission of this article were briefly discussed. Once advised as blanket therapy for all patients, recent reports of hydroxychloroquine with or without azithromycin indicated no potential benefit and use of such combination may increase the risk of arrhythmias. Clinical evidence with newer antivirals such as remdesivir and favipiravir is promising that can hasten the patient recovery and reduce the mortality. With steroids, evidence is much clear in that it should be used in low dose and for short period not extending beyond 7 days in moderate to severe hospitalized patients. Low-molecular-weight heparin should be initiated in all hospitalized COVID-19 patients and dose should be based on the coagulation profile and risk of thromboembolism. Immunomodulatory drugs such tocilizumab may be considered for severe and critically ill patients to improve the outcomes. Though ulinastatin can be a potential alternative immunomodulator, there is lack of clinical evidence on its usage in COVID-19. Convalescent plasma therapy can be potentially lifesaving in critically ill patients. However, there is need to generate further evidence with various such therapies. Though availability of a potent vaccine is awaited, current treatment of COVID-19 is based on available therapies, which is guided by the evidence. In this review, we discuss the potential treatments available around the globe with current evidence on each of such treatments.
Identifiants
pubmed: 33132570
doi: 10.5005/jp-journals-10071-23470
pmc: PMC7584839
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
838-846Informations de copyright
Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.
Déclaration de conflit d'intérêts
Source of support: Nil Conflict of interest: None
Références
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3390-3396
pubmed: 32271456
Clin Pharmacol Ther. 2020 Oct;108(4):762-765
pubmed: 32378737
J Glob Infect Dis. 2020 May 22;12(2):47-93
pubmed: 32773996
Br J Clin Pharmacol. 2009 Sep;68(3):318-9
pubmed: 19740388
J Infect Public Health. 2016 May-Jun;9(3):227-30
pubmed: 27095301
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
J Biol Chem. 2020 May 15;295(20):6785-6797
pubmed: 32284326
Antiviral Res. 2020 Jun;178:104786
pubmed: 32251767
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Travel Med Infect Dis. 2020 May - Jun;35:101710
pubmed: 32360327
Autoimmun Rev. 2020 Jul;19(7):102568
pubmed: 32376398
Lancet. 2020 May 30;395(10238):1695-1704
pubmed: 32401715
J Antimicrob Chemother. 2010 Apr;65 Suppl 2:ii5-ii10
pubmed: 20215135
Drug Discov Ther. 2020;14(1):58-60
pubmed: 32147628
BMC Pulm Med. 2019 Nov 4;19(1):196
pubmed: 31684936
Circulation. 2020 Jun 16;141(24):e906-e907
pubmed: 32267732
Ter Arkh. 2017;89(10):66-70
pubmed: 29171473
J Med Virol. 2020 Jul;92(7):740-746
pubmed: 32227493
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):4040-4047
pubmed: 32329881
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Thromb Haemost. 2020 May;18(5):1020-1022
pubmed: 32239799
Int J Antimicrob Agents. 2020 May;55(5):105938
pubmed: 32171740
Engineering (Beijing). 2020 Oct;6(10):1192-1198
pubmed: 32346491
Med. 2020 Dec 18;1(1):105-113.e4
pubmed: 32838353
N Engl J Med. 2020 Sep 3;383(10):994
pubmed: 32649078
J Med Virol. 2020 Jul;92(7):814-818
pubmed: 32253759
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):260-261
pubmed: 32352517
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532
pubmed: 32359035
JAMA. 2020 Apr 28;323(16):1582-1589
pubmed: 32219428
J Med Virol. 2012 Jan;84(1):170-81
pubmed: 22028179
Cell Discov. 2020 Mar 18;6:16
pubmed: 32194981
Med J Aust. 2020 May;212(9):416-420
pubmed: 32266987
Crit Care Explor. 2020 Apr 29;2(4):e0111
pubmed: 32426753
Pharmacol Res. 2020 Aug;158:104899
pubmed: 32407959
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
Front Physiol. 2020 Mar 26;11:273
pubmed: 32273851
JAMA. 2020 Jun 23;323(24):2493-2502
pubmed: 32392282
Clin Infect Dis. 2020 Nov 19;71(16):2114-2120
pubmed: 32427279
Med Mal Infect. 2020 Jun;50(4):384
pubmed: 32240719
Turk J Med Sci. 2020 Apr 15;50(SI-1):611-619
pubmed: 32293834
Pharmacol Res. 2020 Jul;157:104874
pubmed: 32360581
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
N Engl J Med. 2020 Jun 18;382(25):2411-2418
pubmed: 32379955
JAMA Intern Med. 2020 Aug 1;180(8):1118-1119
pubmed: 32347894
JAMA. 2019 Oct 1;322(13):1261-1270
pubmed: 31573637
Crit Care Med. 2020 Jun;48(6):e440-e469
pubmed: 32224769
J Transl Med. 2020 Apr 14;18(1):164
pubmed: 32290839
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Immun Ageing. 2020 Nov 14;17(1):34
pubmed: 33292350
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Antiviral Res. 2020 Jun;178:104791
pubmed: 32275914
J Med Virol. 2020 Apr;92(4):424-432
pubmed: 31981224
Clin Microbiol Infect. 2020 Jul;26(7):917-921
pubmed: 32344167
World J Pediatr. 2020 Jun;16(3):219-221
pubmed: 32026147
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Indian J Crit Care Med. 2020 Jun;24(6):429-434
pubmed: 32863636